Jamal Oulad Hadj

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 168 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment

Dave E. W. van der Kruijssen, Sjoerd G. Elias, Geraldine R. Vink et al. · JAMA Surgery · 2021 · 53 citations · Full text

Medicine, Oncology, Surgery +17

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst et al. · The Lancet Oncology · 2024 · 43 citations · Full text

Medicine, Oncology, Radiology +14

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

Dinja T. Kruger, Maurice P.H.M. Jansen, Inge R. Konings et al. · Molecular Oncology · 2019 · 20 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma

Jamal Oulad Hadj, ROGIER DEN BRAVEN, CORRINE TILLIER et al. · Oncology Letters · 2012 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17